The following is a summary of “A clot waveform analysis-based system for differential diagnosis of prolonged activated ...
GlobalData on MSN3d
Sirus Therapeutics announces positive signals from Phase I siRNA trialThe Phase I trial of the company’s SRSD107 siRNA therapy found the treatment to be safe and well tolerated as part of its ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback